Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Exiris s.r.l. logo — Preclinical stage company focused on oncology research

Exiris s.r.l.

Preclinical stage company focused on oncology research

Founded 2010 Italy Italy 6 employees

General Information

Company Name Exiris s.r.l.
Founded Year 2010
Location Italy Italy +2
Employees 6
Social

Get notified when Exiris s.r.l. moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Exiris s.r.l.

Exiris s.r.l. is a preclinical stage company based in Italy, founded in 2010, with a focus on oncology research. The company's slogan, "Preclinical stage company focused on oncology research," reflects its core mission. Exiris utilizes a unique combination of technology platforms to discover novel oncology targets and develop innovative therapeutic agents for treating oncology indications with high unmet medical need.

As of now, there is no publicly disclosed information about the company's last investment and the investors involved. However, given the ongoing global emphasis on advancing oncology research and treatment, Exiris's innovative approach to identifying therapeutic targets and agents presents an intriguing investment opportunity within the oncology-focused biotech landscape.

Taxonomy: Oncology Research, Preclinical Stage, Technology Platforms, Therapeutic Agents, Novel Targets, Innovative Research, High Unmet Medical Need

No funding data available for Exiris s.r.l. yet.

Get notified when Exiris s.r.l. raises funding

Exiris s.r.l. Alternatives & Competitors

Exiris s.r.l. vs
Sumitomo Pharma Oncology
Sumitomo Pharma Oncology United States

is part of Sumitomo Pharma America as of July 2023

49 employees
Health Care, Health and Wellness
Exiris s.r.l. vs
HCG Manavata Cancer Centre
HCG Manavata Cancer Centre India

One of the Best and Comprehensive Cancer Centre in India

259 employees
Health Care
Exiris s.r.l. vs
Aster Insights
Aster Insights United States

Accelerating oncology medical product discovery and development through our scientific and clinical...

Private Equity
78 employees
Biotechnology, Health Care

FAQ About Exiris s.r.l.

Preclinical stage company focused on oncology research
Exiris s.r.l. was founded in 2010.
Exiris s.r.l. is headquartered in Italy.
Exiris s.r.l. has approximately 6 employees.
Top alternatives and competitors to Exiris s.r.l. include Sumitomo Pharma Oncology, HCG Manavata Cancer Centre, Aster Insights, Icon Group, KazIOR. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Exiris s.r.l. and Sumitomo Pharma Oncology are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Exiris s.r.l. and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy